Ring-Opening of Lactones with Alkynyltrifluoroborates: A New Route to Functionalized α-Alkynones

Jan Doubský; Ludvík Streinz; Ladislav Lešetický; Bohumír Koutek

doi:10.1055/s-2003-39297

LETTER

Ring-Opening of Lactones with Alkynyltrifluoroborates: A New Route to Functionalized α-Alkynones

Jan Doubský^a, Ludvík Streinz^a, Ladislav Lešetický^b, Bohumír Koutek*^a
^a Institute of Organic Chemistry and Biochemistry, 166 10 Prague 6, Czech Republic
Fax: +420(2)24310177; e-Mail: koutek@uochb.cas.cz;
^b Department of Organic Chemistry, Charles University, 120 00 Prague 2, Czech Republic

Abstract

All articles of this category

Abstract

Alkynyltrifluoroborate salts, readily generated in situ by the addition of BF₃˙OEt₂ to alkynyllithiums, were shown to mediate the regioselective acyl C-O ring cleavage of 5-, 6-, and 7-membered lactones. This novel, operationally simple and high yielding (85-99%) reaction allows a convenient and rapid access to α-alkynones substituted with valuable functional groups.

Key words

alkynes - lactones - ring-opening - alkynyltrifluoroborates - hydroxy α-alkynones

Full Text

References

<A NAME="RG04103ST-1">1</A> Perlmutter P. Conjugate Addition Reactions in Organic Synthesis, Tetrahedron Organic Chemistry Series Vol. 9: Pergamon Press; Oxford: 1992. p.339

For recent examples, see:

<A NAME="RG04103ST-2A">2a</A> Arcadi A. Martinelli F. Rossi E. Tetrahedron 1999, 55: 13233

<A NAME="RG04103ST-2B">2b</A> Wang X. Tan J. Zhang L. Org. Lett. 2000, 2: 3107

<A NAME="RG04103ST-2C">2c</A> Jeevanandam A. Narkunan K. Ling Y.-C. J. Org. Chem. 2001, 66: 6014

<A NAME="RG04103ST-2D">2d</A> Kataoka T. Kinoshita H. Kinoshita S. Iwamura T. Tetrahedron Lett. 2002, 43: 7039

<A NAME="RG04103ST-3A">3a</A> Tam SY.-K. Klein RS. De las Haras FG. Fox JJ. J. Org. Chem. 1979, 44: 4854

<A NAME="RG04103ST-3B">3b</A> Adlington R. Baldwin JE. Pritchard GJ. Spencer KC. Tetrahedron Lett. 2000, 41: 575 ; and references cited therein

<A NAME="RG04103ST-4A">4a</A> Midland MM. Nguyen NH. J. Org. Chem. 1981, 46: 4108

<A NAME="RG04103ST-4B">4b</A> Sayo N. Azuma K.-I. Mikama K. Nakai T. Tetrahedron Lett. 1984, 25: 565

<A NAME="RG04103ST-5A">5a</A> Babudri F. Fiandanese V. Hassan O. Punzi A. Naso F. Tetrahedron 1998, 54: 4327

<A NAME="RG04103ST-5B">5b</A> Hermitage SA. Roberts SM. Watson DJ. Tetrehedron Lett. 1998, 39: 3567

<A NAME="RG04103ST-5C">5c</A> Shimizu Y. Kiyota H. Oritani T. Tetrahedron Lett. 2000, 41: 3141

For recent examples, see:

<A NAME="RG04103ST-6A">6a</A> Yu S. Li N.-S. Kabalka GW. J. Org. Chem. 1999, 64: 5822

<A NAME="RG04103ST-6B">6b</A> Reisser M. Maier A. Maas G. Synlett 2002, 1459

<A NAME="RG04103ST-6C">6c</A> Reddy MVR. Rearick JP. Hoch N. Ramachandran PV. Org. Lett. 2001, 3: 19

<A NAME="RG04103ST-6D">6d</A> Kataoka T. Kinoshita H. Kinoshita S. Iwamura T. Tetrahedron Lett. 2002, 43: 7039

<A NAME="RG04103ST-7A">7a</A> Tohda Y. Sonogashira K. Hagihara N. Synthesis 1977, 777

<A NAME="RG04103ST-7B">7b</A> Hauptman H. Mader M. Synthesis 1978, 307

<A NAME="RG04103ST-7C">7c</A> Verkruijsse HD. Heus-Kloos YA. Brandsma L. J. Orgmet. Chem. 1988, 289

<A NAME="RG04103ST-8A">8a</A> Brown HC. Racherla US. Singh SM. Tetrahedron Lett. 1984, 25: 2411

<A NAME="RG04103ST-8B">8b</A> Hegde VB. Renga JM. Owen JM. Tetrahedron Lett. 2001, 42: 1847

<A NAME="RG04103ST-9A">9a</A> Martin R. Romea P. Tey C. Urpi F. Vilarrasa J. Synlett 1997, 1414

<A NAME="RG04103ST-9B">9b</A> Jackson MM. Leverett C. Toczko JF. Roberts JC. J. Org. Chem. 2002, 67: 5032

<A NAME="RG04103ST-10A">10a</A> Chabala JC. Vincent JE. Tetrahedron Lett. 1978, 937

<A NAME="RG04103ST-10B">10b</A> Wedler C. Schick H. J. Prakt. Chem. 1993, 335: 410

<A NAME="RG04103ST-10C">10c</A> Kel’in AV. Gevorgyan V. J. Org. Chem. 2002, 67: 95

<A NAME="RG04103ST-10D">10d</A> Deslongchamps P. Rowan DD. Pothier N. Sauvé T. Saunders JK. Can. J. Chem. 1981, 59: 1105

<A NAME="RG04103ST-10E">10e</A> Tu YQ. Hübener A. Zhang H. Moore CJ. Fletcher MT. Hayes P. Dettner K. Francke W. McErlean CSP. Kitching W. Synthesis 2000, 1956

<A NAME="RG04103ST-10F">10f</A> Hayes P. Fletcher MT. Moore CJ. Kitching W. J. Org. Chem. 2001, 66: 2530

<A NAME="RG04103ST-11A">11a</A> Negishi EI. Bagheri V. Chatterjee S. Luo FT. Miller JA. Soll AT. Tetrahedron Lett. 1983, 24: 5181

<A NAME="RG04103ST-11B">11b</A> Logue MW. Teng K. J. Org. Chem. 1982, 47: 2549

<A NAME="RG04103ST-11C">11c</A> Kukusava N. Yamaguchi K. Kurita J. Tsuchiya T. Tetrahedron Lett. 2000, 41: 4143

<A NAME="RG04103ST-11D">11d</A> Grotjahn DB. Van S. Combs D. Lev DA. Schneider Ch. Rideout M. Meyer Ch. Hernandez G. Mejorado L. J. Org. Chem. 2002, 67: 9200

<A NAME="RG04103ST-12A">12a</A> Ramachandran PV. Teodorovic AV. Rangaishenvi MV. Brown HC. J. Org. Chem. 1992, 57: 2379

<A NAME="RG04103ST-12B">12b</A> Chowdhury C. Kundu NG. Tetrahedron 1999, 55: 7011

For recent examples see:

<A NAME="RG04103ST-13A">13a</A> Li P. Fong WM. Chao LCF. Fung SHC. Williams ID. J. Org. Chem. 2001, 66: 4087

<A NAME="RG04103ST-13B">13b</A> Pérollier C. Sorokin AB. Chem. Commun. 2002, 1548

<A NAME="RG04103ST-14">14</A> Arcadi A. Cacchi S. Marinelli F. Pace P. Sanzi G. Synlett 1995, 823

<A NAME="RG04103ST-15">15</A> Larson DP. Heathcock CD. J. Org. Chem. 1997, 62: 8407

<A NAME="RG04103ST-16">16</A> Masquelin T. Obrecht D. Synthesis 1995, 276

<A NAME="RG04103ST-17">17</A> Palombi L. Arista L. Lattanzi A. Bonadies F. Scettri A. Tetrahedron Lett. 1996, 37: 7849

<A NAME="RG04103ST-18A">18a</A> Hermitage SA. Roberts SM. Watson DJ. Tetrahedron Lett. 1998, 39: 3567

<A NAME="RG04103ST-18B">18b</A> Serrat X. Cabarrocas G. Rafel S. Ventura M. Linden A. Villalgordo JM. Tetrahedron: Asymmetry 1999, 10: 3417

<A NAME="RG04103ST-19">19</A> Katritzky AR. Lang H. J. Org. Chem. 1995, 60: 7612

<A NAME="RG04103ST-20A">20a</A> Rů˛ička J. Koutek B. Streinz L. aman D. Leetick L. Tetrahedron: Asymmetry 1999, 10: 3521

<A NAME="RG04103ST-20B">20b</A> Vrkočová P. Kalinová B. Valterová I. Koutek B. Talanta 2003, 59: 107

Low yields of alkynone intermediates were observed when conditions analogous to those used in the original protocol were employed to transform lactones into spiroacetals. [10c] [d]

<A NAME="RG04103ST-22">22</A> Yamamoto N. Isobe M. Tetrahedron 1993, 49: 6581

General Procedure for the Synthesis of Alkynones 4: To a solution of alkyne 1 (8 mmol) in dry THF (25 ml) at -78 °C, n-BuLi (5 mL, 1.6 M, 8 mmol) was slowly added, maintaining an argon atmosphere. The reaction mixture was stirred for 20 min, allowed to warm to about -30 °C. The solution was cooled to -78 °C again, and BF₃˙Et₂O (1 mL, 7.9 mmol) was added dropwise. Stirring was continued for 10 min, and then lactone 3 (7.2 mmol) was added in one portion via syringe. The resulting mixture was allowed to warm to room temperature within 1 h, a solution of saturated NH₄Cl-NH₃(aq) 2:1 (5 mL) was added, the mixture was poured into water (50 mL), and extracted with Et₂O (4 × 25 mL). The combined ethereal layers were washed with brine, dried briefly with MgSO₄, and evaporated to afford the crude product as a slightly yellow oil. The crude material was purified by chromatography on silica gel (hexane/10-30% EtOAc) to yield the alkynone 4.
Selected analytical data:4a: ¹H NMR (200 MHz, CDCl₃): δ = 1.72 (br s, 1 H), 1.91 (m, 2 H, CH₂), 2.64 (m, 2 H, CH₂), 2.68 (t, 2 H, J = 6.7 Hz), 3.64 (t, 2 H, J = 6.7 Hz), 3.65 (t, 2 H, J = 6.1 Hz), 4.56 (s, 2 H), 7.34 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 20.44, 26.74, 42.08, 61.77, 67.12, 73.08, 81.33, 91.18, 127.70 (2 C), 127.83, 128.45 (2 C), 137.65, 187.82. IR (CHCl₃): 3489 (br, OH), 2217 (C≡C), 1670 (C=O) cm^-1. GC-MS (EI); m/z (%): 246 (<1) [M⁺], 228 (2), 159 (5), 105 (8), 91 (100), 77(19), 65 (20).
4b: ¹H NMR (200 MHz, CDCl₃): δ = 1.32 (d, 3 H, J = 6.2 Hz), 1.72 (bs, 1 H), 1.91 (m, 2 H, CH₂), 2.61 (m, 2 H, CH₂), 2.66 (m, 2 H, CH₂), 3.65 (t, 2 H, J = 6.2 Hz), 3.75 (m, 1 H, CH), 4.54 (d, 1 H, J = 11.6 Hz), 4.60 (d, 1 H, J = 11.6 Hz), 7.34 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 19.73, 26.61, 26.76, 42.13, 61.77, 70.80, 72.57, 82.02, 91.20, 127.61 (2 C), 127.71, 128.42 (2 C), 138.09, 187.83. IR (CHCl₃): 3472 (br, OH), 2216 (C≡C), 1670 (C=O) cm^-1. GC-MS (EI); m/z (%): 259 (<1) [M⁺ - 1], 198 (5), 169 (3), 105 (5), 91 (100), 77 (21), 65 (18).
4c: ¹H NMR (200 MHz, CDCl₃): δ = 1.52 (d, 3 H, J = 6.7 Hz), 1.95 (tt, 2 H, J = 6.1 Hz and 6.9 Hz), 2.73 (t, 2 H, J = 6.9 Hz), 3.68 (t, 2 H, J = 6.1 Hz), 4.37 (q, 1 H, J = 6.7 Hz), 4.51 (d, 1 H, J = 11.6 Hz), 4.78 (d, 1 H, J = 11.6 Hz), 7.35 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 21.29, 26.55, 42.12, 61.70, 64.24, 71.10, 83.96, 91.58, 127.95, 127.97 (2 C), 128.48 (2 C), 137.23, 187.32. IR (CHCl₃): 3500 (br, OH), 2212 (C≡C), 1676 (C=O) cm^-1. GC-MS (EI); m/z (%): 228(3) [M⁺ - 18], 185(11), 105(10), 91(100), 77(43), 65(29).
4d: ¹H NMR (400 MHz, CDCl₃): δ = 1.06 (s, 9 H, 3 × CH₃), 1.21 (d, 3 H, J = 6.1 Hz), 1.61 (br s, 1 H), 1.88 (tt, 2 H, J = 6.2 Hz and 7.1 Hz), 2.47 (m, 2 H, CH₂), 2.62 (t, 2 H, J = 7.1 Hz), 3.64 (t, 2 H, J = 6.2 Hz), 4.04 (m, 1 H, CH), 7.41 (m, 6 H), 7.67 (m, 4 H). ¹³C NMR (100 MHz, CDCl₃): δ = 19.16, 23.08, 26.71, 26.87 (3 C), 29.49, 42.09, 61.83, 67.43, 82.20, 91.61, 127.63 (4 C), 129.75 (2 C), 133.76 (2 C), 135.75 (4 C), 187.77. IR (CHCl₃): 3482 (br, OH), 2214 (C≡C), 1669 (C=O) cm^-1. GC-MS (EI); m/z (%): 407 (<1) [M⁺ - 1], 390 (3), 333 (100), 289 (38), 259 (31), 233 (66), 211 (71), 135 (85), 105 (42), 77 (34).
4e: ¹H NMR (200 MHz, CDCl₃): δ = 0.93 (t, 3 H, J = 7.3 Hz), 1.35-1.65 (m, 4 H, 2 × CH₂), 1.73 (br s, 1 H), 1.92 (tt, 2 H, J = 7.1 Hz and 6.3 Hz), 2.37 (t, 2 H, J = 6.8 Hz), 2.68 (t, 2 H, J = 7.1 Hz), 3.67 (t, 2 H, J = 6.3 Hz). ¹³C NMR (100 MHz, CDCl₃): δ = 13.42, 18.59, 21.90, 26.76, 29.65, 42.14, 61.80, 80.77, 94.90, 188.11. IR (CHCl₃): 3466 (br, OH), 2213 (C≡C), 1670 (C=O) cm^-1. GC-MS (EI); m/z (%): 168 (<1) [M⁺], 150 (24), 124 (19), 109 (100), 79 (68), 67 (25), 53 (34).
4f: ¹H NMR (200 MHz, CDCl₃): δ = 1.83 (bs, 1 H), 2.00 (tt, 2 H, J = 7.2 Hz and 6.3 Hz), 2.83 (t, 2 H, J = 7.2 Hz), 3.72 (t, 2 H, J = 6.3 Hz), 7.42 (m, 3 H), 7.57 (m, 2 H). ¹³C NMR (100 MHz, CDCl₃): δ = 26.80, 42.13, 61.78, 87.72, 91.10, 119.84, 128.59 (2 C), 130.72, 133.02 (2 C), 187.82. IR (CHCl₃): 3471 (br, OH), 2203 (C≡C), 1664 (C=O) cm^-1. GC-MS (EI); m/z (%): 188 (1) [M⁺], 170 (19), 144 (13), 129 (100), 115 (11), 102 (29), 75 (20).
4g: ¹H NMR (200 MHz, CDCl₃): δ = 1.45-1.90 (m, 5 H, 2 × CH₂ and OH), 2.59 (t, 2 H, J = 7.3 Hz), 2.67 (t, 2 H, J = 6.7 Hz), 3.62 (t, 2 H, J = 6.1 Hz), 3.64 (t, 2 H, J = 6.7 Hz), 4.56 (s, 2 H), 7.35 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 20.08, 20.42, 31.79, 44.98, 62.21, 67.14, 73.07, 81.32, 90.92, 127.69 (2 C), 127.82, 128.44 (2 C), 137.65, 187.89. GC-MS (EI); m/z (%): 242 (3) [M⁺ - 18], 198 (1), 183 (5), 159 (4), 105 (9), 91 (100), 77 (22), 65 (21).
4h: ¹H NMR (200 MHz, CDCl₃): δ = 1.32 (d, 3 H, J = 6.1 Hz), 1.57 (m, 2 H, CH₂), 1.72 (m, 2 H, CH₂), 2.59 (m, 2 H, CH₂), 2.61 (m, 2 H, CH₂), 3.62 (t, 2 H, J = 6.1 Hz), 3.76 (m, 1 H, CH), 4.53 (d, 1 H, J = 11.6 Hz), 4.60 (d, 1 H, J = 11.6 Hz), 7.34 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 19.74, 20.12, 26.59, 31.79, 45.02, 62.21, 70.80, 72.59, 82.02, 90.95, 127.61 (2 C), 127.71, 128.41 (2 C), 138.09, 187.91. GC-MS (EI); m/z (%): 256 (1) [M⁺ - 18], 211 (6), 198 (1), 183 (4), 105 (5), 91 (100), 77 (18), 65 (19).
4i: ¹H NMR (400 MHz, CDCl₃): δ = 1.52 (d, 3 H, J = 6.7 Hz), 1.60 (m, 2 H, CH₂), 1.78 (m, 2 H, CH₂), 2.63 (t, 2 H, J = 7.2 Hz), 3.66 (t, 2 H, J = 6.3 Hz), 4.37 (q, 1 H, J = 6.7 Hz), 4.52 (d, 1 H, J = 11.7 Hz), 4.78 (d, 1 H, J = 11.7 Hz), 7.36 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 20.03, 21.30, 31.74, 45.03, 62.22, 64.25, 71.09, 83.97, 91.39, 127.95 (3 C), 128.48 (2 C), 137.24, 187.41. IR (CHCl₃): 3512 (br, OH), 2212 (C≡C), 1675 (C=O) cm^-1. GC-MS (EI); m/z (%): 242 (<1) [M⁺ - 18], 199 (10), 185 (5), 135 (4), 108 (20), 91 (100), 77 (31), 65 (14).
4j: ¹H NMR (400 MHz, CDCl₃): δ = 0.93 (t, 3 H, J = 7.4 Hz), 1.44 (m, 2 H, CH₂), 1.53-1.63 (m, 4 H, 2 × CH₂), 1.70 (br s, 1 H), 1.74 (m, 2 H, CH₂), 2.37 (t, 2 H, J = 7.0 Hz), 2.59 (t, 2 H, J = 7.4 Hz), 3.65 (t, 2 H, J = 6.4 Hz). ¹³C NMR (100 MHz, CDCl₃): δ = 13.41, 18.58, 20.13, 21.90, 29.66, 31.80, 45.03, 62.22, 80.78, 94.62, 188.19. IR (CHCl₃): 3479 (br, OH), 2213 (C≡C), 1667 (C=O) cm^-1. GC-MS (EI); m/z (%): 182 (<1) [M⁺], 164 (13), 135 (6), 109 (100), 79 (46), 67 (24), 55 (21).
4k: ¹H NMR (200 MHz, CDCl₃): δ = 1.47 (br s, 1 H), 1.64 (m, 2 H, CH₂), 1.83 (m, 2 H, CH₂), 2.74 (t, 2 H, J = 7.1 Hz), 3.69 (t, 2 H, J = 6.2 Hz), 7.42 (m, 3 H), 7.57 (m, 2 H). ¹³C NMR (100 MHz, CDCl₃): δ = 20.22, 31.83, 45.05, 62.25, 87.73, 90.86, 119.89, 128.59 (2C), 130.68, 133.00 (2C), 187.88. IR (CHCl₃): 3506 (br, OH), 2204 (C≡C), 1665 (C=O) cm^-1. GC-MS (EI); m/z (%): 202 (<1) [M⁺], 184 (15), 129 (100), 115 (8), 102 (31), 75 (14).
4l: ¹H NMR (400 MHz, CDCl₃): δ = 1.20 (d, 3 H, J = 6.3 Hz), 1.67 (bs, 1 H), 1.69-1.87 (m, 2 × 1 H, CH₂), 2.67 (t, 2 H, J = 6.8 Hz), 2.69 (m, 2 H, CH₂), 3.64 (t, 2 H, J = 6.8 Hz), 3.81 (ddq, 1 H, J = 4.3 Hz, 6.3 Hz and 7.9 Hz), 4.56 (s, 2 H, CH₂), 7.28-7.38 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 20.44, 23.56, 32.82, 41.85, 67.09, 67.13, 73.07, 81.37, 91.05, 127.69 (2 C), 127.82, 128.45 (2 C), 137.66, 187.95. GC-MS (EI); m/z (%): 242(2) [M⁺-18], 183 (2), 159 (4), 105 (8), 91 (100), 77 (19), 65 (17).
4m: ¹H NMR (400 MHz, CDCl₃): δ = 1.19 (d, 3 H, J = 6.0 Hz), 1.32 (d, 3 H, J = 6.1 Hz), 1.65 (br s, 1 H), 1.77 (m, 2 H, CH₂), 2.55 (dd, 1 H, J = 17.2 Hz and 6.3 Hz), 2.66 (dd, 1 H, J = 17.2 Hz and 5.3 Hz), 2.69 (t, 2 H, J = 7.3 Hz), 3.76 (m, 1 H, CH), 3.80 (m, 1 H, CH), 4.54 (d, 1 H, J = 11.9 Hz), 4.59 (d, 1 H, J = 11.9 Hz), 7.27-7.35 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 19.73, 23.54, 26.60, 32.84, 41.88, 67.07, 70.78, 72.57, 82.05, 91.07, 127.59 (2C), 127.69, 128.40 (2 C), 138.09, 187.96. IR (CHCl₃): 3484 (br, OH), 2214 (C≡C), 1669 (C=O) cm^-1. GC-MS (EI); m/z (%): 256 (<1) [M⁺ - 18], 212 (3), 183 (2), 155 (4), 135 (5), 105 (4), 91 (100), 77 (15), 65 (14).
4n: ¹H NMR (400 MHz, CDCl₃): δ = 1.38 (m, 2 H, CH₂), 1.56 (m, 2 H, CH₂), 1.68 (m, 2 H, CH₂), 2.55 (t, 2 H, J = 7.5 Hz), 2.67 (t, 2 H, J = 6.6 Hz), 3.62 (t, 2 H, J = 6.2 Hz), 3.64 (t, 2 H, J = 6.6 Hz), 4.56 (s, 2 H, CH₂), 7.27-7.38 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 20.41, 23.64, 25.06, 32.29, 45.29, 62.50, 67.15, 73.05, 81.36, 90.71, 127.66 (2 C), 127.80, 128.43 (2 C), 137.66, 187.98. GC-MS (EI); m/z (%): 274 (<1) [M⁺], 202 (6), 159 (7), 105 (5), 91 (100), 79 (10), 65(12).
4o: ¹H NMR (400 MHz, CDCl₃): δ = 0.93 (t, 3 H, J = 7.3 Hz), 1.36-1.48 (m, 4 H, 2 × CH₂), 1.52 (br s, 1 H), 1.53-1.62 (m, 4 H, 2 × CH₂), 1.69 (m, 2 H, CH₂), 2.37 (t, 2 H, J = 7.1 Hz), 2.55 (t, 2 H, J = 7.3 Hz), 3.65 (t, 2 H, J = 6.6 Hz). ¹³C NMR (100 MHz, CDCl₃): δ = 13.43, 18.58, 21.90, 23.75, 25.09, 29.68, 32.34, 45.36, 62.56, 80.83, 94.43, 188.27. IR (CHCl₃): 3482 (br, OH), 2213 (C≡C), 1666 (C=O) cm^-1. GC-MS (EI); m/z (%): 196 (<1) [M⁺], 178 (2), 167 (4), 124 (42), 109 (100), 95 (9), 79 (41), 67 (12).

<A NAME="RG04103ST-24A">24a</A> Yamaguchi M. Shibato K. Fujiwara S. Hirao I. Synthesis 1986, 421

<A NAME="RG04103ST-24B">24b</A> Linderman RJ. Lonikar MS. J. Org. Chem. 1988, 53: 6013

<A NAME="RG04103ST-24C">24c</A> Ramachandran PV. Gong B. Teodorovic’ AV. Brown HC. Tetrahedron: Asymmetry 1994, 5: 1061

<A NAME="RG04103ST-24D">24d</A> Aubrecht KB. Winemiller MD. Collum DB. J. Am. Chem. Soc. 2000, 122: 11084 ; and the references cited therein

<A NAME="RG04103ST-25A">25a</A> Darses S. Michaud G. Genet J.-P. Eur. J. Org. Chem. 1999, 1875

<A NAME="RG04103ST-25B">25b</A> Frohn H.-J. Adonin NY. Bardin VV. Starichenko VF. Tetrahedron Lett. 2002, 43: 8111

<A NAME="RG04103ST-25C">25c</A> Batey RA. Quach TD. Tetrahedron Lett. 2001, 42: 9099

<A NAME="RG04103ST-25D">25d</A> Molander GA. Katona BW. Machrouhi F. J. Org. Chem. 2002, 67: 8416 ; and references cited therein